about
Hyperbolastic growth models: theory and applicationMolecular biology of breast cancer metastasis. The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer.Classical mathematical models for description and prediction of experimental tumor growth14C BOMB-PULSE DATING AND STABLE ISOTOPE ANALYSIS FOR GROWTH RATE AND DIETARY INFORMATION IN BREAST CANCER?Estimating Tumor Growth Rates In Vivo.Probing the invasiveness of prostate cancer cells in a 3D microfabricated landscapeDetection of cancer before distant metastasisBreast cancer tumor growth estimated through mammography screening dataThe growth law of primary breast cancer as inferred from mammography screening trials data.Dynamics of multiple myeloma tumor therapy with a recombinant measles virus.Analysis of inter-patient variations in tumour growth rateGrowth of breast cancer recurrences assessed by consecutive MRIModeling protective anti-tumor immunity via preventative cancer vaccines using a hybrid agent-based and delay differential equation approach.Optimizing chemotherapy dose and schedule by Norton-Simon mathematical modeling.A Systems Biology Approach in Therapeutic Response Study for Different Dosing Regimens-a Modeling Study of Drug Effects on Tumor Growth using Hybrid SystemsThe dynamics of drug resistance: a mathematical perspectiveOverestimated lead times in cancer screening has led to substantial underestimation of overdiagnosisSimplifying the complexity of resistance heterogeneity in metastasisCancer stem cells: small subpopulation or evolving fraction?Mathematical modeling of tumor-tumor distant interactions supports a systemic control of tumor growth.Dynamics of melanoma tumor therapy with vesicular stomatitis virus: explaining the variability in outcomes using mathematical modeling.Tumour doubling times and the length bias in breast cancer screening programmes.Robust nonparametric estimation of monotone regression functions with interval-censored observations.The effect of one additional driver mutation on tumor progression.Dynamics of targeted cancer therapyA stochastic model of cancer growth subject to an intermittent treatment with combined effects: reduction in tumor size and rise in growth rate.Estimating screening test sensitivity and tumour progression using tumour size and time since previous screening.Evaluating different breast tumor progression models using screening data.Sentinel lymph node biopsy: strategies for pathologic examination of the specimen.Variable renewal rate and growth properties of cell populations in colon crypts.The response of tumours with Gompertzian growth characteristics to fractionated radiotherapy.Retrospective cost-effectiveness analysis of screening mammography.A Stochastic Optimal Control Model for BCG Immunotherapy in Superficial Bladder CancerBCG immunotherapy optimization on an isoperimetric optimal control problem for the treatment of superficial bladder cancerImpulsive control dosing BCG immunotherapy for non-muscle invasive bladder cancer
P2860
Q24791971-1EFD24CE-0E59-4377-AB04-7FA34DEE2A07Q24801047-A43EB908-3B8A-44F0-969C-4E2BE535D809Q27321175-5990CDF6-541D-42B1-A71A-3911809F877FQ28601090-9BCCFC4E-ED3A-4F1F-A99B-8597933D7018Q30373100-D62699FD-EFDE-492A-AA37-F3E95833945AQ30499933-65CCBC1F-A938-4436-8073-1372ACF66D5CQ30540711-A40DCCF6-C6CD-43F9-AC12-B386348D6410Q31154970-CAA90A48-58B6-43F4-8A61-5BCC00465F3CQ32039484-CAD080D4-42C0-4861-8E3E-58EA866E516EQ33652517-5D084D59-1233-47F9-821B-D01A08F51481Q33673495-BC2EE288-1B76-4D63-8089-8B8EE9ACA9C1Q33884067-F4E1BDCF-7C56-47BF-9AD7-053CB03BC0ADQ34468868-11D40F6D-5BBA-471F-83D2-C21FA5558CADQ35585064-39105DE7-DC0C-420F-A8FE-CABFAFAB61B5Q35817902-844F4F11-FBA5-42B4-9052-8B47C3DD0766Q35946514-552612C7-452A-4D75-8291-86D423D33AA0Q37214228-B228915D-F98E-425E-931A-2D84408769FDQ37655188-9D905F11-3D1E-4F8A-B17F-3BACD3F65318Q38264074-73C169F8-3074-415C-96B9-AA2A8F64AA21Q38669169-E83A4A28-96D3-4DB6-A16C-2D65E45C6E05Q39473679-C218894F-D515-4D6E-9B4C-C2477F1CFAEEQ39755212-D266D6A7-667E-47BF-8FBF-5BFFFBD41A78Q40117274-30BAAB97-A2AC-4DE3-A194-13DE05A41782Q41846748-B911A4EB-34D9-41F0-8B2B-58489834C0FCQ42197906-C1E5E06C-19F7-4FC7-B2D1-7AB553DFA308Q47428876-433E120E-562C-4B03-9E9A-47D2326F24B4Q47438355-6E852F0D-96C6-4723-8F97-44130E1A54CFQ49796264-F5102FC8-ADC4-4500-81F6-0B93D27EA174Q50520750-B58B1539-C956-43BB-965D-150FD03A0F94Q51657328-73D0751C-CB7A-4361-8417-2DEFCD626309Q52256436-887D15EF-A283-4220-9BD1-CF59A7A9EDE7Q53241570-C0E6BC7E-DA55-48AF-A824-D6F39F925370Q58195990-4C90BE33-DB8E-4CE6-AF34-C45ACCD0C762Q58196006-79BCED36-D3EF-4AB0-8FF0-231EA96F9070Q58196020-5A48429E-037A-4BEA-9731-2E2C46D66179
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Decelerating growth and human breast cancer.
@en
Decelerating growth and human breast cancer.
@nl
type
label
Decelerating growth and human breast cancer.
@en
Decelerating growth and human breast cancer.
@nl
prefLabel
Decelerating growth and human breast cancer.
@en
Decelerating growth and human breast cancer.
@nl
P2093
P1433
P1476
Decelerating growth and human breast cancer.
@en
P2093
von Fournier D
P304
P356
10.1002/1097-0142(19930315)71:6<2013::AID-CNCR2820710615>3.0.CO;2-V
P407
P577
1993-03-01T00:00:00Z